Figure 1 from OPG-Producing B Cells and RANKL-Expressing T Cells Define Immune Signatures Predictive of Bone Metastases in Breast Cancer

Read full text
Authors: Ana Carolina Monteiro, Diego D. Garcia, Ana Paula Gregório Alves Fontão, Bárbara Du Rocher, Maria E. Globa Masset, Isabella N. Alves, Lucas Gonçalves Carvalho, Cecília Vianna De Andrade, Gabriel Fidalgo, Marcos V. Colaço, Liebert Parreiras Nogueira, Maria de Fátima Dias Gauí
+1 more Adriana Bonomo
Cited by: 0

Abstract

67NR-derived CD19+ IgD+ IgM+ CD138− B cells are the major source of OPG and inhibit in vitro osteoclastogenesis mediated by soluble factors derived from 4T1 tumor CD3+ T cells. A, Quantification of OPG secretion by total BM cells isolated from distinct skeletal sites: femur, tibia, vertebrae, humerus, and calvaria, of tumor-free, 67NR tumor–bearing, and 4T1 tumor–bearing mice at day 35 after implantation. A total of 107 BM cells/mL were cultured in vitro for 12 hours, and OPG levels in supernatants were measured by ELISA. B, CD19+ B cells isolated from the iliac BM of naive, 67NR-bearing, or 4T1-bearing mice were sorted into CD19+ IgD+ IgM+ CD138− (mature cells) and CD19+ IgD− IgM− CD138+ (plasm-like cells) subsets and were cultured in vitro (106 cells/mL) for 12 hours, and OPG levels in supernatants were measured by ELISA. C, Experimental scheme: (i) 11 days after 4T1 tumor cell injection, CD3+ T cells were isolated from iliac BM and stimulated with naive splenic CD11c+ DCs pulsed with 4T1 sAg. Supernatants were harvested after 72 hours of incubation and referred to as CM T 4T1. (ii) Thirty-five days after 67NR tumor cell injection, CD19+ B cells were isolated from iliac BM and stimulated with 4T1 sAg. Supernatants were harvested after 24 hours of incubation and referred to as CM B 67NR. (iii) OC assays were performed with M-CSF plus either RANKL or CM T 4T1, added to naive total BM cells, in the absence or presence of CM B 67NR. D, Quantification of TRAP+ multinucleated OC cells was determined (magnification 40×). E, Functional assessment of OC-mediated resorption using the BD BioCoat Osteologic Bone Cell Culture System. All data are from three independent experiments and are presented as mean ± SD of 4 to 5 mice/group. Statistical comparisons between more than two groups were performed using one-way ANOVA followed by Tukey post hoc test for pairwise comparisons when data were normally distributed. Statistical significance was considered when P < 0.05; *, P < 0.05; **, P < 0.01; ****, P < 0.0001.

Fields of Study & Subjects

Bone Metabolism and Diseases T-cell and B-cell Immunology Cancer Immunotherapy and Biomarkers

Publication details

Publication date
13 January 2026